secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPLASH BEVERAGE GROUP, INC. (SBEV)
CIK:        0001553788
Form:       8-K/A
Filed at:   2026-07-30T20:10:52+00:00
Accession:  0001731122-26-000990
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Splash Beverage expands CannEpil license to veterinary therapeutics; royalty 10% on vet revenue
--------------------------------------------------------------------------------

- Expanded exclusive global license for CannEpil to include veterinary applications; royalty 10% of net revenue for vet, 15% for human.
- Initial focus on companion-animal oncology and chronic pain management; canine indications expected first.
- Global veterinary pain management market ~$2.6B in 2024, projected ~$3.8B by 2030; veterinary oncology market $900M-$1.7B.
- Company finalizing strategic joint venture with established cannabinoid pharmaceutical company to lead vet development.
- CannEpil is EU-GMP manufactured, has IND for human program; will pursue FDA Center for Veterinary Medicine pathways.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/0001731122-26-000990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/e7816_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer